Baldwin Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$204K Buy
+579
New +$206K 0.02% 208
2025
Q2
Sell
-704
Closed -$219K 210
2025
Q1
$219K Buy
+704
New +$208K 0.03% 195
2023
Q2
Sell
-895
Closed -$216K 197
2023
Q1
$216K Sell
895
-385
-30% -$94.5K 0.04% 193
2022
Q4
$336K Sell
1,280
-5
-0.4% -$1.34K 0.06% 161
2022
Q3
$290 Hold
1,285
0.06% 170
2022
Q2
$313 Hold
1,285
0.06% 180
2022
Q1
$311 Sell
1,285
-350
-21% -$80.4K 0.05% 199
2021
Q4
$368 Sell
1,635
-270
-14% -$57K 0.06% 188
2021
Q3
$405K Sell
1,905
-1,575
-45% -$363K 0.07% 175
2021
Q2
$848K Sell
3,480
-850
-20% -$209K 0.14% 113
2021
Q1
$1.08M Sell
4,330
-5
-0.1% -$1.19K 0.2% 93
2020
Q4
$997K Buy
4,335
+150
+4% +$34.6K 0.2% 91
2020
Q3
$1.06M Buy
+4,185
New +$1.04M 0.25% 72

Other funds holding AMGN

Baldwin Investment Management's AMGN Position: Q1 2026 in Review

Baldwin Investment Management opened a new position in Amgen (AMGN) in Q1 2026: 579 shares worth $204K. The stake represents 0.02% of the portfolio and ranks #208 among its holdings. This is a return to the name: Baldwin Investment Management previously reported a position in AMGN as recently as Q1 2025.

Baldwin Investment Management first reported a position in AMGN in Q3 2020 and has held it in 13 quarters since. The position peaked at $1.08M in Q1 2021. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Baldwin Investment Management held 579 shares of Amgen worth $204K as of Q1 2026.
  • Amgen was a new Baldwin Investment Management position in Q1 2026.
  • Amgen made up 0.02% of Baldwin Investment Management's portfolio in Q1 2026, its #208 holding.
  • Baldwin Investment Management first reported a position in Amgen in Q3 2020 and has held it in 13 quarters since.
  • Baldwin Investment Management's Amgen position peaked at $1.08M in Q1 2021.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Baldwin Investment Management's 13F filing for Q1 2026, filed 12 May 2026.